The role of HDAC5 in CD13‐mediated sorafenib resistance was further investigated, and we found that HDAC5 knockdown could enhance HCC cells to be sensitive toward sorafenib in cell lines with high CD13 expression (Figure 5H). This evidence concerns the gene HDAC5 and hepatocellular carcinoma.